Fukuda Denshi Co Ltd
TSE:6960

Watchlist Manager
Fukuda Denshi Co Ltd Logo
Fukuda Denshi Co Ltd
TSE:6960
Watchlist
Price: 7 160 JPY -0.83% Market Closed
Market Cap: 206.4B JPY
Have any thoughts about
Fukuda Denshi Co Ltd?
Write Note
Fukuda Denshi Co Ltd
/
Balance Sheet
/
Additional Paid In Capital

Fukuda Denshi Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Fukuda Denshi Co Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Fukuda Denshi Co Ltd
TSE:6960
Additional Paid In Capital
¥17.5B
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
6%
Terumo Corp
TSE:4543
Additional Paid In Capital
¥51.6B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Olympus Corp
TSE:7733
Additional Paid In Capital
¥91.6B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Sysmex Corp
TSE:6869
Additional Paid In Capital
¥20.8B
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
3%
Nihon Kohden Corp
TSE:6849
Additional Paid In Capital
¥9.7B
CAGR 3-Years
-3%
CAGR 5-Years
-1%
CAGR 10-Years
-1%
JEOL Ltd
TSE:6951
Additional Paid In Capital
¥21.3B
CAGR 3-Years
0%
CAGR 5-Years
16%
CAGR 10-Years
9%
No Stocks Found

Fukuda Denshi Co Ltd
Glance View

Market Cap
206.4B JPY
Industry
Health Care

Fukuda Denshi Co Ltd. is a stalwart in the medical technology arena, having carved out a niche as a leading provider of innovative medical devices and systems. Founded in the mid-20th century, the company has stayed true to its mission of enhancing global healthcare with cutting-edge solutions. Over the years, Fukuda Denshi has evolved its product range to encompass a wide array of essential medical equipment, including electrocardiographs, patient monitoring systems, and ultrasonic diagnosis devices. These products are instrumental in hospitals and clinics for accurate patient diagnostics and monitoring, crucial for effective medical decision-making and improved patient outcomes. The company's journey from a modest operation to a global player is a testament to its commitment to research and development, enabling it to produce technologically advanced and reliable products. Fukuda Denshi's revenue model is primarily driven by the sales of its medical devices and systems across various healthcare settings globally. The company continually invests in innovation, ensuring that its products maintain a competitive edge in terms of functionality and reliability. By forming strategic alliances and partnerships, Fukuda Denshi expands its market reach and supports its distribution channels effectively. Additionally, the company provides comprehensive after-sales services, including maintenance and training, ensuring that healthcare providers can optimize the use of its devices. This service component not only enhances customer satisfaction but also establishes long-term relationships, contributing to recurring revenue streams and sustained business growth. Through a business model synergizing product excellence and strategic market engagement, Fukuda Denshi has solidified its position in the healthcare industry, meeting the growing demands for quality medical technology worldwide.

Intrinsic Value
9 164.38 JPY
Undervaluation 22%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Fukuda Denshi Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
17.5B JPY

Based on the financial report for Sep 30, 2024, Fukuda Denshi Co Ltd's Additional Paid In Capital amounts to 17.5B JPY.

What is Fukuda Denshi Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
6%

Over the last year, the Additional Paid In Capital growth was -20%. The average annual Additional Paid In Capital growth rates for Fukuda Denshi Co Ltd have been -7% over the past three years , -4% over the past five years , and 6% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.